Sort
64,565 grants matching “drug discovery”
Mechanisms of cardioprotective Y RNA signaling in macrophages
$694,252Ahmed Ibrahim · Cedars-Sinai Medical Center · R01 · FY2025 · HL
In silico safety pharmacology
$694,248Colleen E Clancy · University Of California At Davis · R01 · FY2024 · HL
Alzheimer's disease drug development
$694,239Nigel H. Greig · National Institute On Aging · ZIA · FY2021 · AG
HTS of small molecule-protein interactions
$694,180Dale N Larson · Harvard Medical School · R01 · FY2006 · HG
Centralized assay datasets for modelling support of small drug discovery organizations
$694,172Sean Ekins · Collaborations Pharmaceuticals, Inc. · R44 · FY2018 · GM
Risk Factors for Ischemic Stroke in Women
$694,154Kathryn M Rexrode · Brigham And Women'S Hospital · R01 · FY2023 · HL
Single-cell resolution analysis of chromatin accessibility and gene expression changes in a model of drug addiction
$694,115Francesca Telese · University Of California, San Diego · U01 · FY2022 · DA
Development of Novel Antiviral Agents VS West Nile Virus
$694,081Washington University · U01 · FY2005 · AI
Ultrasound-Mediated Blood-Brain Barrier Permeabilization in Primates
$694,061Matthew Swan Lawrence · Virscio, Inc. · R44 · FY2008 · NS
Systematic Alzheimer's disease drug repositioning (SMART) based on bioinformatics-guided phenotype screening and image-omics
$694,058Stephen Tc Wong · Methodist Hospital Research Institute · R01 · FY2018 · AG
Multilevel Parallelization of Software for Accurate Protein-Ligand Affinities
$693,998Simon Webb · Verachem, Llc · R44 · FY2012 · GM
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1
$693,945Robert Daniel Toto · Ut Southwestern Medical Center · KL2 · FY2016 · TR
Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study
$693,860Daniel Hal Solomon · Brigham And Women'S Hospital · R01 · FY2014 · HL
AI-Powered Quantitative Systems Pharmacology for AD Drug Repurposing
$693,857Lei Xie · Hunter College · R01 · FY2023 · AG
Ubiquitin-independent targeted protein degradation
$693,785Lizbeth K. Hedstrom · Brandeis University · R01 · FY2021 · GM
Harnessing mutant IDH1 as a therapeutic target in liver cancer and other solid malignancies
$693,781Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2025 · CA
NEW ANTICANCER DRUGS FOR CULTURED AND COLLECTED MARINE O
$693,767University Of California San Diego · U19 · FY2003 · CA
Anti-inflammatory drug target to reduce adverse pregnancy outcomes.
$693,743Suhas Kallapur · University Of California Los Angeles · R01 · FY2023 · HD
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
$693,720Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
Antibacterial inhibitors of RnpA
$693,668Paul M. Dunman · University Of Rochester · R01 · FY2022 · AI
Genotype-guided therapy for atrial fibrillation
$693,420Dawood Darbar · University Of Illinois At Chicago · R01 · FY2021 · HL
Novel Therapeutics for Cardiovascular Disease
$693,407Sasantha Jeson Sangaralingham · Mayo Clinic Rochester · R01 · FY2023 · HL
Discovery of long-acting, chemoprotective antimalarial compounds
$693,310Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2023 · AI
Analysis of protein interactions in neurodegenerative disease
$693,264John Robert Yates · Scripps Research Institute, The · R01 · FY2022 · AG
Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery
$693,256James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR